Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Endocrinology
•
Bone and Calcium Disorders
•
Primary Care
Do you recommend the use of Denosumab for osteoporosis management in patients receiving IVIG therapy?
Related Questions
How frequently do you monitor for hypocalcemia in patients on romosozumab?
For patients with eGFR around 30, do you still consider using reclast or evenity at adjusted doses?
What is your approach to managing symptomatic primary hyperparathyroidism in the third trimester of pregnancy?
How do you approach management of osteoporosis in patients post lung transplant?
How do you approach a patient with elevated bone specific ALP (>2X the normal limit), but no other evidence of Paget's disease?
Would you continue Forteo treatment past the recommended 2 years if T scores remain low and procollagen (P1NP) is elevated and if so, how would you monitor response?
As part of work up for hyperparathyroidism, what form of calcium replacement(dietary or supplements) would you recommend in a patient with a history of gastric bypass and multiple calcium containing kidney stones?
When do you recommend using trabecular bone score (TBS) for managing osteoporosis?
Are SGLT2 inhibitors contraindicated in patients with osteoporosis and history of vertebral and hip fractures?
How do you manage osteoporosis treatment following parathyroidectomy for primary hyperparathyroidism?
